Cost Curve News - News - https://www.costcurvenews.com/blog/page/8/

Oversight of 340B, as Measured by Audits/Audit Findings, Is Woefully Lagging, New Analysis Finds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Why You Should Account for Generics When Thinking About U.S. Prices, and How the IRA Will Raise Prices for Seniors

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

The Administration Continues to Make Headlines — But Not Policy — on Pharma Issues

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

Lilly Expands Its Pharm-to-Table Offering, Promotes a Lower Price for Consistent Use

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

Regulating DTC Is All the Rage, Suddenly. But It Turns Out that Americans Do Want to Hear from Brands

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

Vaccine Politics and Policy Have Gone Off the Rails. Let’s Hope Reimbursement Stays on Track

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

There Has Been a Small Deluge of MFN News Over the Past 24 Hours, But Does It Matter?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

A Parade of Pharma Execs Have Been Asked About MFN This Week, and the Commentary Is (Unintentionally) Revealing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

MFN ‘Conversations’ Have Started, Pfizer’s Bourla Says, But There’s Not Much There There

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv